Loading...
Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
A demonstration of cardiovascular safety is mandatory for all newly developed glucose-lowering agents, including insulin analogues. The vascular benefit of insulin is evident from the Diabetes Control and Complication Trial (DCCT) and United Kingdom Prospective Diabetes Study (UKPDS), and the cardio...
Na minha lista:
| Udgivet i: | Diabetes Ther |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Healthcare
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5380497/ https://ncbi.nlm.nih.gov/pubmed/28197833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-017-0235-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|